FP
GILD icon

FDO Partners’s Gilead Sciences GILD Stock Holding History

FDO Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,430
Closed -$809K – 248
2017
Q2 		$809K Sell
11,430
-9,847
-46% -$655K 0.17% 187
2017
Q1 		$1.45M Buy
+21,277
New +$1.5M 0.36% 120
2016
Q4 		– Sell
-11,433
Closed -$905K – 222
2016
Q3 		$905K Buy
11,433
+5,242
+85% +$426K 0.39% 111
2016
Q2 		$516K Buy
+6,191
New +$549K 0.28% 141

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FDO Partners's GILD Position: Q3 2017 in Review

FDO Partners sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 11,430 shares — an estimated $809K sold.

FDO Partners first reported a position in GILD in Q2 2016 and held it in 4 quarters. The position peaked at $1.45M in Q1 2017. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • FDO Partners reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • FDO Partners sold 11,430 Gilead Sciences shares in Q3 2017, an estimated $809K.
  • FDO Partners first reported a position in Gilead Sciences in Q2 2016 and held it in 4 quarters.
  • FDO Partners's Gilead Sciences position peaked at $1.45M in Q1 2017.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on FDO Partners's 13F filing for Q3 2017, filed 13 Nov 2017.